|
000
| 01281nam##2200253za#4500 |
|---|
| 001 | 9.699194 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210625000254 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-23515-8 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-103/2014E-PDF |
|---|
| 110 | 2 |aPublic Health Agency of Canada. |
|---|
| 245 | 14|aThe recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada : |h[electronic resource]|bcommon guidance statement / |cprepared by: Meningococcal B Pilot Project Task Group. |
|---|
| 260 | |aOttawa - Ontario : |bPublic Health Agency of Canada |cMarch 26, 2014. |
|---|
| 300 | |a77p.|bfigs., graphs, references, tables |
|---|
| 500 | |aErratum issued by department July 18, 2014. |
|---|
| 590 | |a14-17|b2014-04-25 |
|---|
| 590 | |a14-30|b2014-07-25 |
|---|
| 775 | 08|tRecommandations concernant l'utilisation du vaccin multicomposant contre le méningocoque de sérogroupe B (4CMenB) au Canada : |w(CaOODSP)9.643155 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s1.41 MB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-103-2014-eng.pdf |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s104 KB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-103-2014-1-eng.pdf |
|---|